Get the Stockscreener App
70.06
1.57%
-1.12
Corcept Therapeutics Inc Stock (CORT) Forecast
The Corcept Therapeutics Inc (CORT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $31.87, representing a -54.51% decrease from the current price of $70.06. The highest analyst price target is $33.27, and the lowest is $30.47.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CORT Price Target
Average 39.76
(-43.25% Downside)
Is Corcept Therapeutics Inc (CORT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.54 | Neutral |
| STOCH(9,6) | 26.78 | Neutral |
| STOCHRSI(14) | 16.42 | Buy |
| MACD(12,26) | -0.4617 | Sell |
| ADX(14) | 27.35 | Buy |
| William %R | -81.91 | Buy |
| CCI(14) | -53.02 | Neutral |
Buy: 3
Sell: 1
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
70.51
Sell
|
71.41
Sell
|
| MA20 |
73.57
Sell
|
72.09
Sell
|
| MA50 |
71.76
Sell
|
70.94
Sell
|
| MA100 |
67.83
Buy
|
67.06
Buy
|
| MA200 |
58.46
Buy
|
58.44
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, CORT could be considered a Neutral, with 17 technical analysis indicators signaling 7 Buy signals, 7 signaling Sell signals and 3 Neutral signals. This suggests that investors should exercise caution when entering new positions on CORT, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 44.54 indicates that CORT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.78 indicates that CORT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 16.42 indicates that CORT is oversold. This suggests that CORT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.35 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -53.02 indicates that CORT is still oversold but not to an extreme extent.
Long-term CORT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Corcept Therapeutics Inc financial reports and earnings history, Corcept Therapeutics Inc (CORT) stock could reach $37.53 by 2030, $100.90 by 2040 and $136.73 by 2050. See the projected annual prices until 2050 of the Corcept Therapeutics Inc stock below:
- Corcept Therapeutics Inc (CORT) is expected to reach an average price of $81.07 in 2035, with a high prediction of $83.85 and a low estimate of $79.92. This indicates an $15.71% rise from the last recorded price of $70.06.
- Corcept Therapeutics Inc (CORT) stock is projected to chart a bullish course in 2040, with an average price target of $100.50, representing an $43.45% surge from its current level. The forecast ranges from a conservative $98.48 to a sky-high $100.90.
- Our analysts predict Corcept Therapeutics Inc (CORT) to jump 75.79% by 2045, soaring from $120.59 to an average price of $123.16, potentially reaching $123.66. While $120.59 is the low estimate, the potential upside is significant.
- Corcept Therapeutics Inc (CORT) stock is expected to climb by 2050, reaching an average of $136.70, a $95.12% jump from its current level. However, a wide range of estimates exists, with high and low targets of $136.73 and $133.12, respectively, highlighting the market's uncertainty.
Corcept Therapeutics Inc Stock (CORT) Year by Year Forecast
Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2025
Corcept Therapeutics Inc Stock (CORT) is expected to reach an average price of $33.25 in 2025, with a high prediction of $40.91 and a low estimate of $25.60. This indicates an -52.54% fall from the last recorded price of $70.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $32.89 | $30.47 | $33.27 | -53.05% |
| August, 2025 | $33.43 | $33.25 | $35.29 | -52.28% |
| September, 2025 | $31.10 | $30.22 | $34.06 | -55.62% |
| October, 2025 | $37.41 | $29.52 | $40.91 | -46.60% |
| November, 2025 | $35.06 | $34.02 | $37.83 | -49.96% |
| December, 2025 | $34.71 | $34.45 | $36.96 | -50.46% |
Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2026
The predicted value for Corcept Therapeutics Inc (CORT) in 2026 is set at an average of $42.32. Estimates vary from a peak of $49.99 to a trough of $34.65, indicating an -39.59% surge from the present price of $70.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $41.14 | $34.65 | $42.37 | -41.28% |
| February, 2026 | $44.61 | $40.73 | $45.47 | -36.32% |
| March, 2026 | $46.73 | $43.94 | $46.95 | -33.30% |
| April, 2026 | $45.81 | $45.55 | $49.99 | -34.62% |
| May, 2026 | $44.71 | $42.00 | $46.15 | -36.19% |
| June, 2026 | $41.99 | $41.55 | $45.30 | -40.07% |
| July, 2026 | $40.82 | $39.07 | $43.99 | -41.74% |
| August, 2026 | $41.34 | $40.74 | $42.20 | -41.00% |
| September, 2026 | $42.12 | $40.93 | $43.35 | -39.88% |
| October, 2026 | $42.13 | $39.88 | $42.29 | -39.86% |
| November, 2026 | $41.80 | $40.45 | $42.33 | -40.33% |
| December, 2026 | $40.48 | $40.48 | $42.41 | -42.22% |
Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Corcept Therapeutics Inc (CORT) is $45.39, with a high forecast of $53.49 and a low forecast of $37.29. This indicates an -35.21% decrease from the last price of $70.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $39.74 | $39.54 | $42.55 | -43.28% |
| February, 2027 | $44.11 | $38.65 | $45.18 | -37.04% |
| March, 2027 | $40.38 | $37.29 | $44.89 | -42.37% |
| April, 2027 | $40.19 | $39.77 | $42.57 | -42.64% |
| May, 2027 | $41.37 | $38.32 | $41.54 | -40.95% |
| June, 2027 | $45.91 | $41.09 | $46.57 | -34.48% |
| July, 2027 | $44.98 | $44.49 | $47.90 | -35.80% |
| August, 2027 | $45.00 | $44.76 | $48.30 | -35.77% |
| September, 2027 | $43.95 | $40.03 | $45.54 | -37.26% |
| October, 2027 | $43.87 | $43.34 | $45.03 | -37.38% |
| November, 2027 | $51.04 | $43.98 | $51.13 | -27.15% |
| December, 2027 | $52.08 | $48.83 | $53.49 | -25.66% |
Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2028
In 2028, Corcept Therapeutics Inc (CORT) is projected to reach an average price of $49.00, with a high projection of $54.58 and a low estimate of $43.41. This indicates an -30.06% fall from the last price of $70.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $49.52 | $49.38 | $52.16 | -29.31% |
| February, 2028 | $49.75 | $48.58 | $50.73 | -28.98% |
| March, 2028 | $52.99 | $49.48 | $53.68 | -24.37% |
| April, 2028 | $50.71 | $48.81 | $54.58 | -27.62% |
| May, 2028 | $45.54 | $44.42 | $50.59 | -35.00% |
| June, 2028 | $49.04 | $44.78 | $49.09 | -30.01% |
| July, 2028 | $48.33 | $47.45 | $50.14 | -31.02% |
| August, 2028 | $46.30 | $43.41 | $48.66 | -33.91% |
| September, 2028 | $48.12 | $46.11 | $48.87 | -31.32% |
| October, 2028 | $50.12 | $47.54 | $50.24 | -28.47% |
| November, 2028 | $49.58 | $49.13 | $51.88 | -29.23% |
| December, 2028 | $48.79 | $47.74 | $50.57 | -30.35% |
Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2029
The 2029 price forecast for Corcept Therapeutics Inc Stock (CORT) is $49.27 on average, with a high prediction of $61.54 and a low estimate of $36.99. This represents an -29.68% decrease from the previous price of $70.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $52.30 | $48.37 | $52.49 | -25.35% |
| February, 2029 | $58.77 | $51.69 | $59.18 | -16.11% |
| March, 2029 | $60.73 | $58.27 | $61.54 | -13.32% |
| April, 2029 | $55.04 | $52.52 | $60.83 | -21.44% |
| May, 2029 | $52.79 | $52.21 | $56.72 | -24.65% |
| June, 2029 | $53.95 | $52.25 | $54.16 | -23.00% |
| July, 2029 | $60.68 | $53.87 | $61.48 | -13.39% |
| August, 2029 | $49.58 | $49.48 | $55.85 | -29.24% |
| September, 2029 | $51.15 | $49.40 | $54.64 | -27.00% |
| October, 2029 | $53.47 | $51.11 | $53.97 | -23.68% |
| November, 2029 | $52.14 | $51.75 | $55.18 | -25.57% |
| December, 2029 | $37.06 | $36.99 | $53.97 | -47.10% |
Corcept Therapeutics Inc Stock (CORT) Price Forecast for 2030
Corcept Therapeutics Inc Stock (CORT) is expected to reach an average price of $41.75 in 2030, with a high forecast of $47.26 and a low forecast of $36.24. This signifies an -40.40% decrease from the last price of $70.06.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $37.33 | $36.24 | $37.53 | -46.72% |
| February, 2030 | $38.00 | $37.32 | $38.65 | -45.76% |
| March, 2030 | $40.29 | $37.98 | $40.39 | -42.49% |
| April, 2030 | $40.78 | $39.84 | $41.36 | -41.79% |
| May, 2030 | $42.90 | $40.50 | $43.68 | -38.76% |
| June, 2030 | $43.74 | $42.42 | $43.84 | -37.57% |
| July, 2030 | $42.71 | $40.95 | $47.26 | -39.04% |
| August, 2030 | $42.76 | $42.55 | $44.09 | -38.97% |
| September, 2030 | $42.98 | $42.23 | $43.12 | -38.65% |
| October, 2030 | $44.51 | $42.94 | $45.47 | -36.47% |
| November, 2030 | $42.13 | $41.48 | $45.70 | -39.86% |
| December, 2030 | $43.68 | $41.48 | $44.56 | -37.65% |
1.91%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):